Recombinant Human Anti-C28H54O2 Soluble TCR (Bgp) (C-Cys) (CAT#: VS-0622-YF4198)
Human TCR (Bgp) recognizes C28H54O2 peptide (lauryl palmitoleate) in the context of CD1a. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- C28H54O2
- Epitope
- lauryl palmitoleate
- MHC
- CD1a
- Clone
- Bgp
- Type
- Soluble TCR (C-Cys)
- Related Disease
- Autoimmune disease
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- C28H54O2; lauryl palmitoleate
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone Bgp"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4198. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: WB, ELISA, FC, IP, FuncS, IF, Neut
Application: ELISA, WB, Neut, Funcs, IHC, Inhib
Application: ELISA, Inhib, FuncS
Application: ELISA, WB, FC, IHC, IP
-4.jpg)
Application: FC, FuncS, IA, IF, IP, IHC
Application: Neut, IHC, Activ, FuncS, IF, ELISA
Application: ELISA, FC, Neut, Inhib
Application: ELISA, WB, IF, FC, IP
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
